Harnessing Natural Killer Cells To Treat Metastatic Small Cell Lung Cancer
Journal of Thoracic Oncology(2021)
摘要
Small cell lung cancer (SCLC) is the most aggressive subtype of lung cancer, characterized by early metastatic spread. Though most patients initially respond to platinum-based chemotherapy, resistance rapidly develops. Recently, T cell based immune checkpoint blockade (ICB) therapy has rejuvenated first-line treatment of SCLC, however patients inevitably exhibit poor overall responses, highlighting the necessity for alternative therapeutic approaches. Natural killer (NK) cells are an innate cytotoxic immune cell type and emerging alternative to T cell-based immunotherapies.
更多查看译文
关键词
small cell lung cancer, natural killer (NK) cells, Immunotherapy
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要